We used single-sample gene set enrichment analysis (ssGSEA) to examine the transcriptional programs linked to IFNγ signaling in 672 newly diagnosed adult AML patients from 3 independent datasets: TCGA4, MD Anderson Cancer Center (MDACC)29, and BEAT-AML3. The gene discussed is RUNX2; the disease is acute myeloid leukemia.